Skip to content

Safety & Efficacy of Jeena Sikho Shuddhi Dr. Hair oil

A Clinical Study to Evaluate the Safety & Efficacy of Jeena Sikho Shuddhi Dr. Hair oil in Hair Growth and hairfall with Phototrichogram - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076531
Enrollment
36
Registered
2024-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair Growth Oil: Test Product: Jeena Sikho Shuddhi Dr. Hair Oil, Dose: approx. 0.5 to 1 ml with help of dropper on bald area with gentle massage twice a day. Duration: 84 Days, Route o

Sponsors

Jeena Sikho Lifcare Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary man or women between 20 and 40 years. 2. Photo type III to V. 3. Having apparently healthy skin on test area 4. For whom the investigator considers that the compliance will be correct. 5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. 6. Having signed a Consent Form. 7. Should be able to read and write (in English, Hindi or local language). 8. Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: 1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2.Having refused to give her assent by not signing the consent form 3.Taking part in another study liable to interfere with this study 4.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area 5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6.Having a progressive asthma (either under treatment or last fit in the last 2 years) 7.Being epileptic 8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) Having cutaneous hypersensitivity 9.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products 10. Following a chronic or intermittent medicinal treatment comprising any of the following products : aspirin-based products, anti-inflammatories, anti-histamines, anti coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 11.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months 12.Having changed her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit 13. Having applied a cosmetic product on the studied areas the first day of the study (except the usual shampoo)

Design outcomes

Primary

MeasureTime frame
1.SGA (Subject Global Assessment) Questionnaire 2.HD Imaging 3.Phototrichoscan AssessmentTimepoint: T0min, T+2 days, T+28 days ,T+30 days, T+56 days T+58 days, T+84 days and T+86 days

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026